{"id":18483,"date":"2024-05-24T20:26:00","date_gmt":"2024-05-24T20:26:00","guid":{"rendered":"http:\/\/model1.caplinpoint.net\/?p=18483"},"modified":"2024-05-25T06:30:05","modified_gmt":"2024-05-25T06:30:05","slug":"caplin-steriles-gets-usfda-approval-for-phenylephrine-hydrochloride-ophthalmic-solution-usp","status":"publish","type":"post","link":"http:\/\/model1.caplinpoint.net\/index.php\/2024\/05\/24\/caplin-steriles-gets-usfda-approval-for-phenylephrine-hydrochloride-ophthalmic-solution-usp\/","title":{"rendered":"CAPLIN STERILES GETS USFDA APPROVAL FOR PHENYLEPHRINE HYDROCHLORIDE OPHTHALMIC SOLUTION USP"},"content":{"rendered":"\n<p><strong>Chennai, May 24, 2024: Caplin Steriles Limited (Caplin),<\/strong> a Subsidiary of Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT), has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Phenylephrine hydrochloride Ophthalmic Solution USP 2.5% and 10% (eye drops), a generic therapeutic equivalent version of the Reference Listed Drug (RLD), from Alcon Research LLC.<\/p>\n\n\n\n<p>Phenylephrine hydrochloride Ophthalmic Solution USP 2.5% and 10% is indicated to dilate the pupil of the eyes. According to IQVIATM (IMS Health), Phenylephrine hydrochloride Ophthalmic Solution USP 2.5% and 10% had US sales of approximately $32 million for the 12-month period ending Mar 2024<\/p>\n\n\n\n<div class=\"wp-block-file\"><a target=\"_blank\" href=\"http:\/\/model1.caplinpoint.net\/wp-content\/uploads\/2024\/04\/CSL_Phenyephrine_ophthalmic_ANDA_Approval_Press_Release.pdf\" class=\"wp-block-file__button\" rel=\"noopener\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Chennai, May 24, 2024: Caplin Steriles Limited (Caplin), a Subsidiary of Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT), has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Phenylephrine hydrochloride Ophthalmic Solution USP 2.5% and 10% (eye drops), a generic therapeutic equivalent&#8230; <\/p>\n","protected":false},"author":1,"featured_media":1229,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/18483"}],"collection":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/comments?post=18483"}],"version-history":[{"count":1,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/18483\/revisions"}],"predecessor-version":[{"id":18484,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/18483\/revisions\/18484"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/media\/1229"}],"wp:attachment":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/media?parent=18483"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/categories?post=18483"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/tags?post=18483"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}